These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 23715070

  • 1. Addition of rifampin to vancomycin for methicillin-resistant Staphylococcus aureus infections: what is the evidence?
    Tremblay S, Lau TT, Ensom MH.
    Ann Pharmacother; 2013; 47(7-8):1045-54. PubMed ID: 23715070
    [Abstract] [Full Text] [Related]

  • 2. Successful treatment of daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus bacteremia with the addition of rifampin to daptomycin.
    Ahmad NM, Rojtman AD.
    Ann Pharmacother; 2010 May; 44(5):918-21. PubMed ID: 20354160
    [Abstract] [Full Text] [Related]

  • 3. Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem.
    Jang HC, Kim SH, Kim KH, Kim CJ, Lee S, Song KH, Jeon JH, Park WB, Kim HB, Park SW, Kim NJ, Kim EC, Oh MD, Choe KW.
    Clin Infect Dis; 2009 Aug 01; 49(3):395-401. PubMed ID: 19569970
    [Abstract] [Full Text] [Related]

  • 4. Clinical efficacy of oral linezolid compared with intravenous vancomycin for the treatment of methicillin-resistant Staphylococcus aureus-complicated skin and soft tissue infections: a retrospective, propensity score-matched, case-control analysis.
    Itani KM, Biswas P, Reisman A, Bhattacharyya H, Baruch AM.
    Clin Ther; 2012 Aug 01; 34(8):1667-73.e1. PubMed ID: 22770644
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infection (cSSTI): a meta-analysis.
    Bounthavong M, Hsu DI.
    Curr Med Res Opin; 2010 Feb 01; 26(2):407-21. PubMed ID: 20001574
    [Abstract] [Full Text] [Related]

  • 6. Treatment of methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia with high-dose vancomycin or linezolid.
    Hamilton LA, Christopher Wood G, Magnotti LJ, Croce MA, Martin JB, Swanson JM, Boucher BA, Fabian TC.
    J Trauma Acute Care Surg; 2012 Jun 01; 72(6):1478-83. PubMed ID: 22695410
    [Abstract] [Full Text] [Related]

  • 7. A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection.
    Schrenzel J, Harbarth S, Schockmel G, Genné D, Bregenzer T, Flueckiger U, Petignat C, Jacobs F, Francioli P, Zimmerli W, Lew DP, Swiss Staphylococcal Study Group.
    Clin Infect Dis; 2004 Nov 01; 39(9):1285-92. PubMed ID: 15494904
    [Abstract] [Full Text] [Related]

  • 8. A stewardship program's retrospective evaluation of vancomycin AUC24/MIC and time to microbiological clearance in patients with methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.
    Gawronski KM, Goff DA, Brown J, Khadem TM, Bauer KA.
    Clin Ther; 2013 Jun 01; 35(6):772-9. PubMed ID: 23795575
    [Abstract] [Full Text] [Related]

  • 9. Early response assessment to guide management of methicillin-resistant Staphylococcus aureus bloodstream infections with vancomycin therapy.
    Joo J, Yamaki J, Lou M, Hshieh S, Chu T, Shriner KA, Wong-Beringer A.
    Clin Ther; 2013 Jul 01; 35(7):995-1004. PubMed ID: 23829982
    [Abstract] [Full Text] [Related]

  • 10. Pharmacodynamic assessment of vancomycin-rifampicin combination against methicillin resistant Staphylococcus aureus biofilm: a parametric response surface analysis.
    Salem AH, Elkhatib WF, Noreddin AM.
    J Pharm Pharmacol; 2011 Jan 01; 63(1):73-9. PubMed ID: 21155818
    [Abstract] [Full Text] [Related]

  • 11. Use of daptomycin to treat infections with methicillin-resistant Staphylococcus aureus isolates having vancomycin minimum inhibitory concentrations of 1.5 to 2 μg/mL.
    McDaneld PM, Spooner LM, Mohr JF, Belliveau PP.
    Ann Pharmacother; 2013 Dec 01; 47(12):1654-65. PubMed ID: 24259618
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
    Campbell ML, Marchaim D, Pogue JM, Sunkara B, Bheemreddy S, Bathina P, Pulluru H, Chugh N, Wilson MN, Moshos J, Ku K, Hayakawa K, Martin ET, Lephart PR, Rybak MJ, Kaye KS.
    Ann Pharmacother; 2012 Dec 01; 46(12):1587-97. PubMed ID: 23212935
    [Abstract] [Full Text] [Related]

  • 16. Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia.
    Maor Y, Hagin M, Belausov N, Keller N, Ben-David D, Rahav G.
    J Infect Dis; 2009 Mar 01; 199(5):619-24. PubMed ID: 19199552
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
    Stein GE, Wells EM.
    Curr Med Res Opin; 2010 Mar 01; 26(3):571-88. PubMed ID: 20055750
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of linezolid-based salvage therapy compared with glycopeptide-based therapy in patients with persistent methicillin-resistant Staphylococcus aureus bacteremia.
    Park HJ, Kim SH, Kim MJ, Lee YM, Park SY, Moon SM, Park KH, Chong YP, Lee SO, Choi SH, Woo JH, Kim YS.
    J Infect; 2012 Dec 01; 65(6):505-12. PubMed ID: 22902942
    [Abstract] [Full Text] [Related]

  • 20. Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study.
    Moore CL, Osaki-Kiyan P, Haque NZ, Perri MB, Donabedian S, Zervos MJ.
    Clin Infect Dis; 2012 Jan 01; 54(1):51-8. PubMed ID: 22109947
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.